Implementing a prospective surveillance and early intervention model of care for breast cancer-related lymphedema into clinical practice: application of the RE-AIM framework.
Bioimpedance spectroscopy (BIS)
Implementation
Lymphedema
Prospective surveillance model (PSM)
RE-AIM framework
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
31
03
2020
accepted:
23
06
2020
pubmed:
3
7
2020
medline:
23
2
2021
entrez:
3
7
2020
Statut:
ppublish
Résumé
Chronic lymphedema following breast cancer (BC) affects individuals physically, functionally, psychologically, and financially. Despite national guidelines and evidence-based research supporting a prospective surveillance and early intervention model of care (PSM), bridging the gap between research and clinical practice has been difficult. As part of an international randomized controlled trial (RCT), Australian women with BC from four hospitals were recruited, monitored for lymphedema at regular intervals over a 3-year period, and were provided a compression garment if intervention was triggered. The reach, effectiveness, adoption, implementation and maintenance (RE-AIM) evaluation framework was used retrospectively to assess a PSM at the individual and organizational level for those who had completed at least 2-year follow-up (N = 219) in the RCT. The application of the RE-AIM framework retrospectively demonstrated an extensive reach to patients across public and private settings; the effectiveness of prospective surveillance and early intervention was achieved through low progression rates to clinical lymphedema (1.8%), and all hospital sites initially approached adopted the research study. Key implementation strategies necessary for effectiveness of this model of care included education to health professionals and patients, staff acceptability, and development of a referral and care pathway. Maintenance dimensions were evaluated both at the individual level with 92-100% adherence rates for all nonoptional study appointments over the 2-year period, and at the organizational-level, PSM was sustained after recruitment ceased for the research study. The PSM for lymphedema in BC can be successfully implemented using the RE-AIM framework applied retrospectively. The implementation of the PSM used in the RCT has assisted in changing clinical practices and improving the quality and effectiveness of the health care system.
Identifiants
pubmed: 32613370
doi: 10.1007/s00520-020-05597-5
pii: 10.1007/s00520-020-05597-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1081-1089Références
Eakin EG, Hayes SC, Haas MR, Reeves MM, Vardy JL, Boyle F, Hiller JE, Mishra GD, Goode AD, Jefford M, Koczwara B, Saunders CM, Demark-Wahnefried W, Courneya KS, Schmitz KH, Girgis A, White K, Chapman K, Boltong AG, Lane K, McKiernan S, Millar L, O’Brien L, Sharplin G, Baldwin P, Robson EL (2015) Healthy living after Cancer: a dissemination and implementation study evaluating a telephone-delivered healthy lifestyle program for cancer survivors. BMC Cancer 15(1):992. https://doi.org/10.1186/s12885-015-2003-5
doi: 10.1186/s12885-015-2003-5
pubmed: 26690258
pmcid: 4687340
Laidley A, Anglin B (2016) The impact of L-Dex(®) measurements in assessing breast cancer-related lymphedema as part of routine clinical practice. Front Oncol 6:192–192. https://doi.org/10.3389/fonc.2016.00192
doi: 10.3389/fonc.2016.00192
pubmed: 27656420
pmcid: 5011139
Koelmeyer LA, Borotkanics RJ, Alcorso J, Prah P, Winch CJ, Nakhel K, Dean CM, Boyages J (2019) Early surveillance is associated with less incidence and severity of breast cancer–related lymphedema compared with a traditional referral model of care. Cancer 125(6):854–862. https://doi.org/10.1002/cncr.31873
doi: 10.1002/cncr.31873
pubmed: 30521080
Stout NL, Pfalzer LA, Springer B, Levy E, McGarvey CL, Danoff JV, Gerber LH, Soballe PW (2012) Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther 92(1):152–163. https://doi.org/10.2522/ptj.20100167
doi: 10.2522/ptj.20100167
pubmed: 21921254
Levenhagen K, Davies C, Perdomo M, Ryans K, Gilchrist L (2017) Diagnosis of upper quadrant lymphedema secondary to cancer: clinical practice guideline from the oncology section of the American Physical Therapy Association. Phys Ther 97(7):729–745
doi: 10.1093/ptj/pzx050
Basta MN, Fox JP, Kanchwala SK, Wu LC, Serletti JM, Kovach SJ, Fosnot J, Fischer JP (2016) Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg 211(1):133–141. https://doi.org/10.1016/j.amjsurg.2015.06.015
doi: 10.1016/j.amjsurg.2015.06.015
pubmed: 26421413
Framework L (2006) Best practice for the management of lymphoedema. International consensus London: MEP Ltd:3–52
Kilgore LJ, Korentager SS, Hangge AN, Amin AL, Balanoff CR, Larson KE, Mitchell MP, Chen JG, Burgen E, Khan QJ (2018) Reducing breast cancer-related lymphedema (BCRL) through prospective surveillance monitoring using bioimpedance spectroscopy (BIS) and patient directed self-interventions. Ann Surg Oncol 25(10):2948–2952
doi: 10.1245/s10434-018-6601-8
Whitworth PW, Cooper A (2018) Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy. Breast J 24(1):62–65. https://doi.org/10.1111/tbj.12939
doi: 10.1111/tbj.12939
pubmed: 29063664
Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M (2011) Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health Ment Health Serv Res 38(2):65–76. https://doi.org/10.1007/s10488-010-0319-7
doi: 10.1007/s10488-010-0319-7
Mitchell SA, Chambers DA (2017) Leveraging implementation science to improve cancer care delivery and patient outcomes. J Oncol Pract 13(8):523–529. https://doi.org/10.1200/JOP.2017.024729
doi: 10.1200/JOP.2017.024729
pubmed: 28692331
pmcid: 5555033
Pullen T, Bottorff JL, Sabiston CM, Campbell KL, Eves ND, Ellard SL, Gotay C, Fitzpatrick K, Sharp P, Caperchione CM (2018) Utilizing RE-AIM to examine the translational potential of Project MOVE, a novel intervention for increasing physical activity levels in breast cancer survivors. Transl Behav Med 9(4):646–655. https://doi.org/10.1093/tbm/iby081
doi: 10.1093/tbm/iby081
Glasgow RE, McKay HG, Piette JD, Reynolds KD (2001) The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management? Patient Educ Couns 44(2):119–127
doi: 10.1016/S0738-3991(00)00186-5
Ridner SH, Dietrich MS, Cowher MS, Taback B, McLaughlin S, Ajkay N, Boyages J, Koelmeyer L, DeSnyder SM, Wagner J, Abramson V, Moore A, Shah C (2019) A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis. Ann Surg Oncol 26:3250–3259. https://doi.org/10.1245/s10434-019-07344-5
doi: 10.1245/s10434-019-07344-5
pubmed: 31054038
pmcid: 6733825
Ridner SH, Dietrich MS (2015) Development and validation of the lymphedema symptom and intensity survey-arm. Support Care Cancer 23(10):3103–3112
doi: 10.1007/s00520-015-2684-y
McLaughlin SA, Stout NL, Schaverien MV (2020) Avoiding the swell: advances in lymphedema prevention, detection, and management. Am Soc Clin Oncol Educ Book 40:1–10. https://doi.org/10.1200/edbk_280471
doi: 10.1200/edbk_280471
pubmed: 32315238
Dylke E (2019) Early detection of breast cancer-related lymphoedema. Australasian Lymphology Association. https://www.lymphoedema.org.au/public/7/files/Position%20Statements/ALA%20Position%20Statement_Early%20Detection%20of%20BCRL.pdf . Accessed February 2020
Phillips SM, Alfano CM, Perna FM, Glasgow RE (2014) Accelerating translation of physical activity and cancer survivorship research into practice: recommendations for a more integrated and collaborative approach. Cancer Epidemiol Biomark Prev 23(5):687. https://doi.org/10.1158/1055-9965.EPI-13-1355
doi: 10.1158/1055-9965.EPI-13-1355
Belkora J, Volz S, Loth M, Teng A, Zarin-Pass M, Moore D, Esserman L (2015) Coaching patients in the use of decision and communication aids: RE-AIM evaluation of a patient support program. BMC Health Serv Res 15(1):209
doi: 10.1186/s12913-015-0872-6
Iina A, Rebecca E (2011) A RE-AIM evaluation of theory-based physical activity interventions. J Sport Exercise Psychol 33(2):198–214. https://doi.org/10.1123/jsep.33.2.198
doi: 10.1123/jsep.33.2.198
Leach H, Danyluk J, Culos-Reed S (2014) Design and implementation of a community-based exercise program for breast cancer patients. Curr Oncol 21(5):267–271
doi: 10.3747/co.21.2079
Johansson K, Branje E (2010) Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis. Acta Oncol 49(2):166–173. https://doi.org/10.3109/02841860903483676
doi: 10.3109/02841860903483676
pubmed: 20100154
Casley-Smith JR (1995) Alterations of untreated lymphedema and it’s grades over time. Lymphology 28(4):174–185
pubmed: 8771010
Powell BJ, Waltz TJ, Chinman MJ, Damschroder LJ, Smith JL, Matthieu MM, Proctor EK, Kirchner JE (2015) A refined compilation of implementation strategies: results from the expert recommendations for implementing change (ERIC) project. Implement Sci 10(1):21. https://doi.org/10.1186/s13012-015-0209-1
doi: 10.1186/s13012-015-0209-1
pubmed: 25889199
pmcid: 4328074
Scholl I, LaRussa A, Hahlweg P, Kobrin S, Elwyn G (2018) Organizational- and system-level characteristics that influence implementation of shared decision-making and strategies to address them — a scoping review. Implement Sci 13(1):40. https://doi.org/10.1186/s13012-018-0731-z
doi: 10.1186/s13012-018-0731-z
pubmed: 29523167
pmcid: 5845212
Dylke ES Early detection of breast cancer-related lymphoedema. [Internet]. NSW: Australasian Lymphology Association; September 201. Available from https://www.lymphoedema.org.au/public/7/files/Position%20Statements/ALA%20Position%20Statement_Early%20Detection%20of%20BCRL.pdf . Accessed 11 Mar 2020
ACI Chronic Care Network. Lymphoedema: a guide for clinical services. [Internet]. NSW: ACI Chronic Care Network; 10 February 2020. Available from: https://www.aci.health.nsw.gov.au/__data/assets/pdf_file/0008/477998/lymphoedema-guide.pdf . Accessed 11 Mar 2020
National Lymphedema Network. Position Paper on screening & early detection of breast-cancer-related lymphedema: the imperative. [Internet]. New York; April 2011. Available from: https://lymphnet.org/position-papers . Accessed 11 Mar 2020
Armer JM, Hulett JM, Bernas M, Ostby P, Stewart BR, Cormier JN (2013) Best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Curr Breast Cancer Rep 5(2):134–144
doi: 10.1007/s12609-013-0105-0
Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112(12):2809–2819. https://doi.org/10.1002/cncr.23494
doi: 10.1002/cncr.23494
pubmed: 18428212
Breast Cancer Network Australia. State of the nation report. [internet]. Australia: BCNA; June 2018. Available from https://www.bcna.org.au/media/6656/sotn-report-lowres.pdf . Accessed 11 Mar 2020
Boyages J, Xu Y, Kalfa S, Koelmeyer L, Parkinson B, Mackie H, Viveros H, Gollan P, Taksa L (2017) Financial cost of lymphedema borne by women with breast cancer. Psycho-oncology 26(6):849–855
doi: 10.1002/pon.4239